n.a. (TSPT)

0.00
OTC BB
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange OTC BB
Div & Yield N.A. (N.A)

Latest News

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

Keep these biotech stocks on your radar.

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Commit To Buy Transcept Pharmaceuticals At $2.50, Earn 20.1% Annualized

Commit To Buy Transcept Pharmaceuticals At $2.50, Earn 20.1% Annualized

Investors eyeing a purchase of Transcept Pharmaceuticals Inc stock, but tentative about paying the going market price of $2.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2014 put at the $2.50 strike, which has a bid at the time of this writing of 30 cents.

Transcept Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

Transcept Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

Transcept Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript

5 Biotech Stocks Poised for Breakouts

5 Biotech Stocks Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

8 Stocks Under $10 Skyrocketing Higher

8 Stocks Under $10 Skyrocketing Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Transcept Pharmaceuticals Inc. Stock Downgraded (TSPT)

Transcept Pharmaceuticals Inc. Stock Downgraded (TSPT)

Transcept Pharmaceuticals (Nasdaq:TSPT) has been downgraded by TheStreet Ratings from from a hold to sell.

Transcept Stock Gaps Down On Today's Open (TSPT)

Transcept Stock Gaps Down On Today's Open (TSPT)

Shares of Transcept Pharmaceuticals (Nasdaq:TSPT) were gapping down Thursday morning with an open price 12.7% lower than Wednesday's closing price. The stock closed at $11 yesterday and opened today's trading at $9.60.

Transcept Stock Hits New 52-Week High (TSPT)

Transcept Stock Hits New 52-Week High (TSPT)

Transcept Pharmaceuticals (Nasdaq:TSPT) hit a new 52-week high Monday as it is currently trading at $11.92, above its previous 52-week high of $11.88 with 407,807 shares traded as of 3 p.m. ET. Average volume has been 382,600 shares over the past 30 days.

8 Stocks Rising on Huge Volume

8 Stocks Rising on Huge Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Transcept Pharmaceuticals Inc. Stock Upgraded (TSPT)

Transcept Pharmaceuticals Inc. Stock Upgraded (TSPT)

Transcept Pharmaceuticals (Nasdaq:TSPT) has been upgraded by TheStreet Ratings from a sell to hold.

Transcept Wins Sleeping Pill Approval

Transcept's Intermezzo will be used by people who wake up in the middle of the night but cannot fall back to sleep.

Biotech Stock Live Chat

TheStreet's biotech columnist Adam Feuerstein is holding a live, interactive discussion about biotech stock investing.

Biotech Calendar: Key Dates for November

Here's a list of November's potentially stock-moving biotech events.

Biotech Stock Mailbag: Somaxon, Transcept

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

5 Stocks Insiders Think Are Worth It

Insiders at these companies have been scooping up shares of their own stock lately.

Insiders Trading HNZ, JEF, ARUN, TSPT

The top 10 open-market insider purchases and sales filed at the SEC Thursday.

10 Stocks to Watch: Transcept, Netflix, UBS

Transcept Pharmaceuticals shares are surging in premarket trading Thursday after the company says it plans to resubmit the new drug application for its proposed insomnia drug Intermezzo by the end of the month.

Clarcor, Transcept: After-Hours Trading

Clarcor and Transcept Pharmaceuticals were seeing heavy trading interest in Wednesday's after-hours session.

Biotech Stock Live Chat

TheStreet's biotech columnist Adam Feuerstein is holding a live, interactive discussion about biotech stock investing.

Transcept Pharmaceuticals Inc. Stock Downgraded (TSPT)

Transcept Pharmaceuticals (Nasdaq:TSPT) has been downgraded by TheStreet Ratings from from a hold to sell.

Transcept Stock Gaps Down On Today's Open (TSPT)

Shares of Transcept Pharmaceuticals (Nasdaq:TSPT) were gapping down Wednesday morning with an open price 42.5% lower than Tuesday's closing price. The stock closed at $8.59 yesterday and opened today's trading at $4.94.

Transcept Pharma: FDA Will Reject Sleeping Pill

Lingering safety concerns cause FDA to reject Transcept's middle-of-the-night sleeping pill for a second time.

Biotech Stock Mailbag: Transcept Pharma

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

10 Biotech Trades for Second Half of 2011

These trades could represent a watershed moment in the lifeline of a biotech company.

Biotech Calendar: 2011 FDA Drug Approvals

An updated list of drug and biotech firms with drug approvals expected in 2011.

Transcept Pharmaceuticals Inc. Stock Upgraded (TSPT)

Transcept Pharmaceuticals (Nasdaq:TSPT) has been upgraded by TheStreet Ratings from a sell to hold.

Transcept Pharmaceuticals Inc. Stock Downgraded (TSPT)

Transcept Pharmaceuticals (Nasdaq:TSPT) has been downgraded by TheStreet Ratings from from a hold to sell.